The title compound (systematic name: 4,10-dinitro-2,6,8,12-tetraoxa-4,10-diazatetracyclo[5.5.0.0(3,11).0(5,9)]dodecane), C(6)H(6)N(4)O(8), exhibits the highest density among known N-nitramines, due to its close-packed crystal structure. It may be regarded as consisting of a distorted hexagonal close-packed lattice formed by the isowurtzitane cages, with the nitro groups occupying the free space between the cages.
No takes yet. Share an insight, caveat, or question.
Karaghiosoff et al. (2002) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: